Chinese scientists will perform the world's first genetic editing trial on humans this month, in an attempt to find a cure for lung cancer. The mortality rate of lung cancer patients is high. The editing therapy treatment periods will last from eight weeks to three months. "This is why we chose cancer patients for the initial trial. "We plan to select ten volunteers, all advanced lung cancer patients who have undergone chemotherapy, radiation therapy and other types of treatment.

Source: dna August 02, 2016 09:11 UTC